Simran Asawa
Overview
Explore the profile of Simran Asawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurzeder C, Nguyen-Strauli B, Krol I, Ring A, Castro-Giner F, Nuesch M, et al.
Nat Med
. 2025 Jan;
PMID: 39856336
The presence of circulating tumor cell (CTC) clusters is associated with disease progression and reduced survival in a variety of cancer types. In breast cancer, preclinical studies showed that inhibitors...
2.
Moorman A, Benitez E, Cambuli F, Jiang Q, Mahmoud A, Lumish M, et al.
Nature
. 2025 Jan;
637(8047):E28.
PMID: 39789339
No abstract available.
3.
Moorman A, Moorman A, Benitez E, Benitez E, Cambuli F, Cambulli F, et al.
Nature
. 2024 Oct;
637(8047):947-954.
PMID: 39478232
As cancers progress, they become increasingly aggressive-metastatic tumours are less responsive to first-line therapies than primary tumours, they acquire resistance to successive therapies and eventually cause death. Mutations are largely...
4.
Simmler P, Ioannidi E, Mengis T, Marquart K, Asawa S, Van-Lehmann K, et al.
Elife
. 2023 Oct;
12.
PMID: 37823551
The splicing factor SF3B1 is recurrently mutated in various tumors, including pancreatic ductal adenocarcinoma (PDAC). The impact of the hotspot mutation SF3B1 on the PDAC pathogenesis, however, remains elusive. Here,...
5.
Asawa S, Nuesch M, Gvozdenovic A, Aceto N
Br J Cancer
. 2023 Mar;
128(11):1981-1990.
PMID: 36932192
Gastrointestinal (GI) cancers account for 35% of cancer-related deaths, predominantly due to their ability to spread and generate drug-tolerant metastases. Arising from different locations in the GI system, the majority...
6.
Siddiqui N, Asawa S, Birru B, Baadhe R, Rao S
Mol Biotechnol
. 2018 May;
60(7):506-532.
PMID: 29761314
Biomaterial-based scaffolds are important cues in tissue engineering (TE) applications. Recent advances in TE have led to the development of suitable scaffold architecture for various tissue defects. In this narrative...
7.
Narain A, Asawa S, Chhabria V, Patil-Sen Y
Nanomedicine (Lond)
. 2017 Oct;
12(21):2677-2692.
PMID: 28965474
Cell membrane coated nanoparticles (NPs) is a biomimetic strategy developed to engineer therapeutic devices consisting of a NP core coated with membrane derived from natural cells such as erythrocytes, white...